-
Jun 30, 2026How to Validate a Pharmacokinetic ModelValidating a pharmacokinetic model is a crucial step in drug development and research. As a pharmacokinetics (PK) “Pharmacokinetics (PK)” supplier, I've seen firsthand how a well - -
Jun 16, 2026Challenges in Pharmacodynamic Modeling and the Role of Translational NHP StudiesExplore the limitations of current pharmacodynamic models and how non-human primate studies, advanced imaging, and translational biomarkers improve prediction of clinical drug resp -
Jun 09, 2026Cynomolgus Monkeys vs. Rhesus Monkeys: Key Differences for Preclinical ResearchLearn the key differences between cynomolgus and rhesus monkeys in genetics, physiology, behavior, and translational research applications to support optimal non-human primate mode -
Jun 08, 2026Can the MCAO NHP Model be used to study the interaction between different bra...Stroke is a leading cause of morbidity and mortality worldwide, with long - term neurological deficits often affecting patients' quality of life. Understanding the interaction betw -
May 22, 2026What is the significance of NHP preclinical studies in drug development?NHP preclinical studies bridge translational gaps in drug development, enabling clinically relevant safety, efficacy, and pharmacology evaluation. -
Apr 27, 2026PK/PD Relationship in Drug Development: Clinical Implications and Translation...Explore the clinical significance of PK/PD relationships in drug development, including dose optimization, CNS delivery, and translational studies using NHP models at Prisys Biotec -
Mar 27, 2026How to measure the infarct volume in the MCAO NHP Model?Measuring the infarct volume in the Middle Cerebral Artery Occlusion (MCAO) Non-Human Primate (NHP) Model is a crucial process in neuroscience research, especially for understandin -
Mar 12, 2026How do PD drugs influence the immune cells in the brain in pharmacology?Parkinson's disease (PD) is a progressively neurodegenerative disorder that ranks second only to Alzheimer's disease in prevalence. It is characterized by the loss of dopamine - pr -
Mar 04, 2026What is the pharmacokinetic profile of inhaled drugs?The pharmacokinetic profile of inhaled drugs is a complex and fascinating area that holds significant importance in the field of medicine and drug development. As a leading Pharmac -
Mar 02, 2026What are the advantages of using an NHP CRO?In the dynamic landscape of pharmaceutical research and development, Non - Human Primate (NHP) Contract Research Organizations (CROs) have emerged as pivotal players. As an NHP CRO -
Feb 26, 2026NHP Selection in Preclinical Research | Translational Strategy & Model Optimi...Explore key methodological considerations in non-human primate (NHP) selection for biomedical research. Learn how species choice, health screening, genetics, and behavioral profili -
Feb 11, 2026How Do Non-Human Primate Preclinical Studies Enable the Development of Geriat...Explore how non-human primate (NHP) preclinical models improve translational accuracy in geriatric drug development, addressing age-related disease biology, PK/PD changes, and safe
